CJC-1295 NO DAC + IPAMORELIN

Dual-Pathway Growth Hormone Signaling Research Blend

For Research Use Only

Overview

CJC-1295 No DAC + Ipamorelin combines two research peptides investigated through complementary pathways within the growth hormone/IGF-1 axis.

CJC-1295 No DAC, commonly referred to as Modified GRF (1-29), is a modified GHRH analog studied for its interaction with pituitary GHRH receptors.

Ipamorelin is a growth hormone secretagogue investigated for its activity at the GHS-R1a (ghrelin) receptor.

Combining these compounds provides researchers with a model for investigating two distinct receptor systems involved in growth-hormone signaling.

Research Areas

The individual components have been investigated in research involving:

• Growth hormone signaling
• GH/IGF-1 axis biology
• Pituitary physiology
• GHRH receptor activity
• Ghrelin/GHS-R1a receptor signaling
• Endocrine regulation
• Metabolic signaling
• Skeletal-muscle physiology
• Tissue-remodeling pathways
• Growth-hormone secretagogue research

Direct controlled human evidence for the specific No-DAC + Ipamorelin combination is limited, so the biological effects of the finished blend should not be assumed from studies of its individual components or from CJC-1295 with DAC.

Two Peptides — Two Research Pathways

CJC-1295 No DAC / Modified GRF (1-29)

Investigated primarily through the:

GHRH → GHRH Receptor → Pituitary GH pathway

The No-DAC form lacks the albumin-binding Drug Affinity Complex responsible for the prolonged activity of the original DAC-containing CJC-1295 molecule.

Ipamorelin

Investigated primarily through the:

GHS-R1a (Ghrelin Receptor) → Pituitary GH pathway

This provides researchers with a mechanistically different route for examining growth-hormone secretagogue signaling.

Why Researchers Study the Combination

The blend is scientifically interesting because the two components target different receptor systems converging on growth-hormone signaling.

Researchers can therefore investigate interactions between:

• GHRH signaling
• Ghrelin-receptor signaling
• Pituitary GH secretion
• Downstream IGF-1 pathways
• Endocrine feedback mechanisms
• Metabolic signaling

Importantly, this mechanistic rationale does not establish that the combination produces superior clinical outcomes in humans. Published human evidence for CJC-1295 specifically concerns the DAC-bearing long-acting analog, while recent reviews describe the No-DAC version as lacking direct controlled human studies.

Product Features

✔ Premium Research Grade
✔ Dual-Peptide Research Blend
✔ CJC-1295 No DAC / Modified GRF (1-29)
✔ Ipamorelin
✔ Third-Party Tested (COA Available)
✔ Identity & Purity Verification
✔ Secure Professional Packaging
✔ Laboratory Research Only

Common Research Applications

Researchers may investigate the individual components or combination in models involving:

• GH/IGF-1 axis biology
• GHRH receptor signaling
• Ghrelin-receptor signaling
• Pituitary physiology
• Endocrine research
• Metabolic pathways
• Skeletal-muscle biology
• Growth-factor signaling

Storage

Store according to the product’s batch-specific stability documentation. Protect lyophilized material from excessive heat, moisture, and direct sunlight. Following laboratory preparation, use validated storage procedures and minimize unnecessary temperature cycling.

Disclaimer

For Research Use Only.

This product is intended exclusively for laboratory research and analytical purposes.

CJC-1295 No DAC and Ipamorelin are investigational research compounds and this combination is not an FDA-approved therapeutic product.

Not intended for human or veterinary use.

Why Choose Voltis Research Co.

At Voltis Research Co., quality starts with knowing exactly what’s inside every vial. For combination products in particular, accurate identity, concentration, and analytical verification are essential.

Qualifying batches undergo independent third-party analytical testing, with batch-specific Certificates of Analysis available to document identity and purity.

The Voltis Commitment

⚡ Research-Grade Quality
⚡ Independent Third-Party Testing
⚡ Batch-Specific Certificate of Analysis (COA)
⚡ High-Purity Research Peptides
⚡ Rigorous Quality Control
⚡ Secure Professional Packaging
⚡ Transparency, Consistency & Reliability

Powering Discovery Through Quality Research.